These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2166346)

  • 1. Chemotherapy for unresectable non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):20-9. PubMed ID: 2166346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in metastatic and locally advanced non-small cell lung cancer.
    Spigel DR; Greco FA
    Semin Surg Oncol; 2003; 21(2):98-110. PubMed ID: 14508860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of unresectable non-small cell lung cancer.
    Livingston RB
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
    van Zandwijk N; Dalesio O
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):66-71. PubMed ID: 8052876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR; Manegold C; Bülzebruck H; Vogt-Moykopf I; Drings P
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in chemotherapy for lung cancer.
    Lilenbaum RC
    Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for advanced non-small cell lung cancer.
    Ichinose Y; Takanashi N; Yano T; Asoh H; Yokoyama H; Tayama K; Hara N; Ohta M
    Natl Med J India; 1996; 9(1):24-5. PubMed ID: 8713521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future beyond platinum for the treatment of advanced non-small cell lung cancer.
    Dragnev KH; Rigas JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):73-6. PubMed ID: 10585012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients.
    Cesano A; Lane SR; Ross GA; Fields SZ
    Int J Oncol; 2000 Sep; 17(3):587-90. PubMed ID: 10938402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.